Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares Genomics Immunology and Healthcare ETF (IDNA) belongs to the BioTech & Genomics segment. Invesco Dynamic Pharmaceuticals ETF (PJP) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. IDNA is less expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.57% for PJP. IDNA is up 10.27% year-to-date (YTD) with +$6M in YTD flows. PJP performs worse with -1.62% YTD performance, and +$89M in YTD flows. Run a side-by-side ETF comparison of IDNA and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IDNA PJP | +0.52%-5.63% | +10.05%-2.63% | +10.27%-1.62% | +33.25%+23.10% | +29.09%+43.13% | -35.97%+35.60% |
| Flows | IDNA PJP | +$6M+$1M | +$6M+$93M | +$6M+$89M | +$2M+$91M | -$21M+$6M | +$479K-$40M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IDNA PJP | +23.81%+15.59% | +25.77%+18.78% | +24.07%+15.36% | +28.18%+15.91% |
| Max drawdown | IDNA PJP | -7.09%-6.91% | -18.64%-13.71% | -30.61%-16.11% | -68.19%-17.41% |
| Max drawdown duration | IDNA PJP | 11d32d | 127d130d | 279d275d | 1635d788d |
IDNA | PJP | |
Last sale 3/13/2026 at 1:30 PM | $28.78 | $101.99 |
| Previous close 03/12/2026 | $28.91 | $102.74 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IDNA | PJP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IDNA | PJP | |
|---|---|---|
| Last price | $28.78 | $101.99 |
| 1D performance | -0.45% | -0.73% |
| AuM | $150.13 M | $395.91 M |
| E/R | 0.47% | 0.57% |
IDNA | PJP | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | Invesco |
| Benchmark | NYSE FactSet Global Genomics and Immuno Biopharma Index | Dynamic Pharmaceutical Intellidex Index |
| N° of holdings | 42 | 29 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 11, 2019 | June 23, 2005 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
